Feature Channels: Pain

• share
• favorite_border

A new study published in Clinical Cardiology introduces the North Indian (NORIN) ST‐Segment Elevation Myocardial Infarction (STEMI) Registry and provides preliminary data collected since its start in January of this year. The prospective cohort study’s first author, Sameer Arora, MD, UNC School of Medicine cardiology fellow and preventive medicine resident

• share
• favorite_border

Routine use of opioids after vasectomy doesn't improve pain control, but is associated with a substantial rate of persistent opioid use in the months after the procedure, reports a study in the October issue of The Journal of Urology®, Official Journal of the American Urological Association (AUA). The Journal is published in the Lippincott portfolio by Wolters Kluwer.

• share
• favorite_border

A team of researchers at the University of Georgia will study how legalized medical cannabis affects people living with chronic pain.

• share
• favorite_border

The University of Illinois at Chicago has received $2.8 million in funding from the National Institutes of Health to investigate non-opioid pain management strategies for people with kidney disease, which affects about 15% of adults in the U.S. With the funding, UIC will be one of eight clinical centers studying alternative pain management solutions for adults on maintenance dialysis

• share
• favorite_border

Dr. Brian Sites, medical director of the acute pain medicine service at Dartmouth-Hitchcock Medical Center, has accepted the position of editor-in-chief for the Regional Anesthesia and Pain Medicine journal.

• share
• favorite_border

Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have discovered a molecular process that controls the rate at which nerves grow both during embryonic development and recovery from injury throughout life.

• share
• favorite_border

The historical practice of mindfulness is a burgeoning integrated medicine field associated with benefits for people with issues ranging from insomnia to chronic pain and fueled by more than $550 million in federal funding over the past 20 years.

• share
• favorite_border

A UC Davis research team, led by Vladimir Yarov-Yarovoy and Heike Wulff, will receive a $1.5 million grant from the National Institutes of Health (NIH) to develop a novel class of peptides that are better at treating pain and don’t have the side effects of opioids. The grant is part of the NIH initiative Helping to End Addiction Long-Term (HEAL Initiative).

• share
• favorite_border

Scientists from the UCLA Integrated Substance Abuse Programs will lead a $25 million National Institutes of Health study testing treatments, including the use of telemedicine, to help fight the opioid epidemic in rural America.

• share
• favorite_border

A new study finds nearly one in three adults with lupus use prescription opioids to manage pain, despite a lack of evidence that opioids are effective for reducing pain from rheumatic diseases.

• share
• favorite_border

There may be some good news for people with vestibular migraine, a type of migraine that causes vertigo and dizziness with or without headache pain. A small, preliminary study suggests that non-invasive nerve stimulation may show promise as a treatment for vestibular migraine attacks, a condition for which there are currently no approved treatments. The study is published in the September 25, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

High-intensity cycling is less painful when combined with virtual reality, according to a new study by University of Georgia researchers.

• share
• favorite_border

Hardly a day goes by without the public being warned about the dangers of opioids. But still, according to the National Institute on Drug Abuse, more than 130 people die every day of opioid overdose and the problem is getting worse. A Houston Methodist pain specialist says new advancements in pain management are giving patients options.

• share
• favorite_border

Whitney Luke, MD, a board certified pain medicine and addiction medicine specialist at The Ohio State University Wexner Medical Center, explains how to properly taper opioid medication.

• share
• favorite_border

The American Chiropractic Association (ACA) is pleased to announce that ACA Senior Scientific Advisor Christine Goertz, DC, PhD, has been appointed by the Comptroller of the United States to a three-year term as chair of the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors.

• share
• favorite_border

The American Chiropractic Association (ACA) and chiropractors nationwide are encouraging the public to take simple steps to better musculoskeletal health during National Chiropractic Health Month (NCHM) this October.

• share
• favorite_border

NYU Langone orthopedic surgeon conducts first-ever foot and ankle arthroscopic treatment with new technology for same-day diagnosis and treatment.

• share
• favorite_border

Americans living with rheumatic disease face significant healthcare challenges, according to a national patient survey released this week by the American College of Rheumatology and its Simple Tasks™ public awareness campaign.

• share
• favorite_border

Results of a recent study suggest that using an alternative MMA regimen of the pain relievers oral acetaminophen and gabapentin, as well as intravenous acetaminophen during surgery, is safe and more effective than conventional pain relief treatments that include opioids. The results were published in the print issue of JAMA on Sept. 1.

• share
• favorite_border

Researchers at New York University (NYU) Oral Cancer Center were awarded a $2.5 million grant from the National Cancer Institute to study the role of artemin in oral cancer pain and growth.

• share
• favorite_border

The Congress of Neurological Surgeons leads, promotes, and supports the creation and methodological processes to produce evidence-based guidelines—critical tools to confront a rapidly changing health care environment.

• share
• favorite_border

A herniated disc is painful – and the most frequent cause of spinal surgery. But is the selected treatment always the right one? New research results show that the clinical criteria

• share
• favorite_border

What makes pelvic pain abnormal? While the answer is different for every woman, having the strength to discuss it with a health care provider may help prevent years of suffering.

• share
• favorite_border

• share
• favorite_border

World champion tennis player, Venus Williams, is teaming up with the American College of Rheumatology (ACR) to share important information about rheumatic diseases in a new public service announcement (PSA) set to air nationwide this fall.

• share
• favorite_border

As the opioid tramadol has grown in popularity so too have documented cases of adverse effects. In a new study, researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego show that patients who take tramadol are at greater risk for hypoglycemia, abnormally low blood sugar.

• share
• favorite_border

• share
• favorite_border

越来越多的消费者使用大麻二酚(CBD)及大麻籽油相关产品来缓解疼痛、焦虑、睡眠障碍及其他慢性病症。但是，此类产品是否安全，效果如何？

• share
• favorite_border

A literature review by a team at the VA Portland Health Care System and Oregon Health & Science University found evidence that biofeedback can be a helpful treatment for several conditions.

• share
• favorite_border

Les huiles de cannabidiol (CBD) et leurs produits dérivés sont devenus de plus en plus populaires auprès des consommateurs, qui peuvent ainsi soulager leurs douleurs, l'anxiété, les troubles du sommeil et d'autres problèmes chroniques. Mais ces produits sont-ils sans danger et sont-ils utiles ?

• share
• favorite_border

Os óleos de canabidiol (CBD) e produtos derivados estão ficando cada vez mais populares entre os consumidores como forma de encontrar alívio para dores, ansiedade, distúrbios do sono e outros problemas crônicos. Porém, esses produtos são seguros? São úteis?

• share
• favorite_border

Los aceites de cannabidiol (CBD) y sus productos derivados se han vuelto cada vez más populares entre los consumidores como una forma de encontrar alivio a dolores, molestias, ansiedad, trastornos del sueño y otros problemas crónicos; pero, ¿son seguros y útiles estos productos?

• share
• favorite_border

Millennials lead the escalating interest in marijuana and cannabinoid compounds for managing pain – with older generations not far behind – and yet most are unaware of potential risks. Three-quarters (75%) of Americans who expressed interest in using marijuana or cannabinoids to address pain are under the impression they are safer or have fewer side effects than opioids or other medications, according to a nationwide survey commissioned by the American Society of Anesthesiologists (ASA).

• share
• favorite_border

Researchers at the University of Health Sciences, Medical Informatics and Technology (UMIT, Hall, Austria) and the University of the Balearic Islands (Palma de Mallorca, Spain) have confirmed the analgesic effects of social support - even without verbal or physical contact.

• share
• favorite_border

A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.

• share
• favorite_border

Using the largest database of real-time recordings of the effects of common and commercially available cannabis products in the United States (U.S.)

• share
• favorite_border

The amount of opioids prescribed for patients after heart and lung surgery has a direct relationship with the risk for opioid dependency and “persistent opioid use” several months after the operation.

• share
• favorite_border

Cannabidiol (CBD) oils and products have become increasingly popular with consumers as ways to find relief from aches and pains, anxiety, sleep disturbances and other chronic issues. But are these products safe, and are they helpful?

• share
• favorite_border

A new study finds that up to 10 percent of people with headaches also have facial pain. The study is published in the August 21, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

A recent study found that people with chronic lower back pain who performed self-administered acupressure experienced improvement in pain and fatigue symptoms.

• share
• favorite_border

Saint Louis University pain researchers will investigate a promising but little understood pain signaling pathway in the hopes of opening up a new avenue for pain medication research.

• share
• favorite_border

With a $2.14 million grant from the National Cancer Institute (NCI), researchers from the Frances Payne Bolton School of Nursing at Case Western Reserve University will measure whether an approach that uses simulation or experiential learning can affectively teach family caregivers not only the skills to take better care of their patient, but better care of their own emotional and physical health amid such incredible stress.

• share
• favorite_border

Patients receiving buprenorphine for treatment of opioid use disorder (OUD) are more likely to use medications for chronic, unrelated conditions, suggests a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

• share
• favorite_border

A new study shows how one state’s surgeons reduced the number of opioids they prescribed to thousands of patients -- without causing patients to feel more pain or less satisfied with their surgical experience.

• share
• favorite_border

AnaBios Corp. today announced it is providing validated human dorsal root ganglion (hDRG) to the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), for research collaborations to develop human cell-based screening platforms and novel drugs to treat pain and opioid use disorder.

• share
• favorite_border

A researcher from the University of Houston has found that adults who take prescription opioids for severe pain are more likely to have increased anxiety, depression and substance abuse issues if they also use marijuana.

• share
• favorite_border

Sixty percent of privately insured children undergoing tonsil removal received opioids –with average prescriptions lasting about six to 10 days – a new study finds.

• share
• favorite_border

An increasing number of Americans are using opioids to treat their migraine headaches, despite the fact that opioids are not the recommended first-line therapy for migraine in most cases. Migraine care specialist Sait Ashina, MD, a neurologist and Director of the Comprehensive Headache Center at the Arnold-Warfield Pain Center at Beth Israel Deaconess Medical Center, presented the survey findings at the 61st annual meeting of the American Headache Society.

• share
• favorite_border

The American Chiropractic Association offers parents tips for choosing a backpack for their children that won't cause back pain and shoulder strain.